Clinical Trials in Los Angeles

Showing 7941-7960 of 16,901 trials

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

NCT02704273

This is a pre-Phase 1 prospective, non interventional clinical assessment study to evaluate XLMTM subjects aged 3 years and younger. Many of these clinically relevant measures have not yet been routinely assessed in this population and may provide important insight on the natural history of XLMTM and for future evaluation of potential therapies.

X-linked Myotubular Myopathy

Astellas Gene Therapies34 participantsStarted Jul 2016

Los Angeles, California, United States • Gainesville, Florida, United States • Chicago, Illinois, United States +5 more locations

COMPLETEDPhase 4< 1 mile

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

NCT00469183

Evaluate atrophogenic potential of long-term use of Tri-Luma Cream on facial Melasma through biopsy examination.

Melasma

Galderma R&D70 participantsStarted May 2006

Los Angeles, California, United States • Dallas, Texas, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

NCT04124926

To evaluate the efficacy and safety of vonoprazan compared to lansoprazole in participants with erosive esophagitis.

Erosive Esophagitis

Phathom Pharmaceuticals, Inc.1,027 participantsStarted Oct 2019

Anniston, Alabama, United States • Athens, Alabama, United States • Birmingham, Alabama, United States +154 more locations

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

Find Trials by Condition in Los Angeles

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

Cefixime for Alternative Syphilis Treatment

A Study to Evaluate the Effect of Lycomato on Skin Attributes in Healthy Participants.

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1

Efficacy and Safety of Human Plasma-derived C1-esterase Inhibitor as add-on to Standard of Care for the Treatment of Refractory Antibody Mediated Rejection (AMR) in Adult Renal Transplant Recipients

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

A Study of Immune Responses to the Virus That Causes COVID-19

A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes